Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Assets (2016 - 2025)

Historic Return on Assets for Iovance Biotherapeutics (IOVA) over the last 12 years, with Q3 2025 value amounting to 0.44%.

  • Iovance Biotherapeutics' Return on Assets changed N/A to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year change of. This contributed to the annual value of 0.44% for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Iovance Biotherapeutics' Return on Assets stood at 0.44%.
  • Iovance Biotherapeutics' 5-year Return on Assets high stood at 0.24% for Q1 2023, and its period low was 0.54% during Q1 2024.
  • In the last 3 years, Iovance Biotherapeutics' Return on Assets had a median value of 0.41% in 2025 and averaged 0.41%.
  • Per our database at Business Quant, Iovance Biotherapeutics' Return on Assets plummeted by -3100bps in 2024 and then surged by 1500bps in 2025.
  • Over the past 3 years, Iovance Biotherapeutics' Return on Assets (Quarter) stood at 0.54% in 2023, then decreased by 0bps to 0.54% in 2024, then grew by 19bps to 0.44% in 2025.
  • Its Return on Assets stands at 0.44% for Q3 2025, versus 0.42% for Q2 2025 and 0.4% for Q1 2025.